Pathologia最新文献

{"title":"Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation","authors":"P. P. Bidzilya, V. H. Kadzharian","doi":"10.14739/2310-1237.2022.3.268186","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.268186","url":null,"abstract":"Aim. To investigate the peculiarities of clinical and laboratory changes and to identify prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction (CHFprEF), excess weight and concomitant atrial fibrillation (AF).\u0000Materials and methods. The open, prospective, cohort study in parallel groups included 248 patients with CHFprEF, overweight and abdominal obesity, average age 65.0 ± 11.0 years; 146 (58.9 %) women and 102 (41.1 %) men. The first group included 181 patients with CHFprEF and excess weight without concomitant AF, and the second group – 67 CHFprEF patients with excess weight and AF. The complex clinical examination was performed according to the standards, including complaints, medical and family history, clinical, laboratory and instrumental examinations.\u0000Results. It has been established that patients with CHFprEF and overweight or abdominal obesity concomitant AF have a predisposition to anemia, which was manifested by significant lower indicators of hemoglobin and erythrocytes in parallel with lower values of lymphocytes, more pronounced signs of systemic inflammation, dysfunction of the kidneys and liver with manifestations of cholestasis, which indicated deeper functional and structural disorders of organs and systems. ROC-analysis of the patients with CHFprEF, excess weight and concomitant AF demonstrated increase in the clinical endpoints rate for patients with BMI ˃32 kg/m2, the waist circumference / hips circumference ratio ˃1.1 U, leucocytes level ˃6 × 109 l, serum creatinine ˃96 mcmol/l, urea ˃7.3 mmol/l, glomerular filtration rate ≤65 ml/min/1.73 m2, LDL / HDL cholesterol ratio ˃2.05 U. The 5-years death predictors were found in patients with CHFprEF, excess weight and concomitant AF: functional class of CHF ˃ІІ, HDL cholesterol ≤0.9 mmol/l, LDL cholesterol ≤0.66 mmol/l and triglycerides ≤1.45 mmol/l; additionally, there were defined the predictors of recurrent admission to hospital with the CHFprEF decompensation: leucocytes level ˃6 × 109 l, LDL cholesterol ˃2.49 mmol/l, the LDL / HDL cholesterol ratio ˃2.05 U and the atherogenic ratio ˃2.91 U.\u0000Conclusions. In patients with CHFprEF and excess weight, concomitant AF was associated with more severe laboratory changes, which reflected deeper functional and structural disorders of organs and systems. Laboratory predictors of the adverse course of CHFprEF in this category of patients have been established.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"30 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84210502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 structure-forming collagens of the nucleus pulposus with degeneration of intervertebral discs L5-L4, L5-S1","authors":"Ye. H. Pedachenko, I. H. Vasylieva, M. Khyzhniak, O. S. Halanta, N. Chopyk, O. Tsiubko, A. B. Hriazov, O. Nekhlopochyn, T. A. Ksenzov, A. Dmytrenko, T. Makarova","doi":"10.14739/2310-1237.2022.3.266942","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.266942","url":null,"abstract":"Aim. The purpose of the work was to determine the relationship between degenerative changes of the L5-S1 and L4-L5 intervertebral discs with collagen mononucleotide variants COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 among ethnic Ukrainians.\u0000Materials and methods. The following subjects were investigated: 90 persons of the case group with degeneration of the intervertebral disc L5-S1; 50 persons of the case group with degeneration of the intervertebral disc L4-L5; 66 people of the control group. The object of the study was the venous blood of patients with degenerative lesions of the intervertebral discs and healthy donors. Venous blood was obtained as a result of venipuncture. Typing of COL2A1rs2276454, COL2A1rs1793953, COL9A1rs1135056, COL11A1rs1676486 was performed using the Tag Man Universal PCR Master Mix kit (Applied Biosystems, USA) and Tag Man SNP Genotyping Assays for the determination of polymorphisms (Applied Biosystems, USA). The research was carried out by specialists in the field of molecular biology and biochemistry of the Department of Neurobiochemistry of the SI “Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine”, using the CFX96 device (Bio-Rrad, USA). Certificate of determination of measuring capabilities No. PT-322/21 from 07/28/2021 to 08/27/2023.\u0000Results. COL2A1rs2276454 may have a protective value for the development of degeneration of the intervertebral disc L5-S1 among men (OR (95 % CI): 0.27 (0.10–0.80), χ2 = 6.02, P = 0.015). Genotype C/T (COL9A1rs1135056) is 3.25 times more common among male patients with degeneration of the intervertebral disc L5-S1 in comparison with the female case group (OR (95 % CI): 3.25 (1.20–8.84), χ2 = 5.50, P = 0.02). The presence of the genotype G/A (COL11A1rs1676486) in the general group of patients with degeneration of the intervertebral disc L5-S1 is observed 5.46 times more often among male patients (OR (95 % CI): 5.46 (1.60–18.47), χ2 = 8.29, P = 0.004); G/A is registered 4.17 times more often among men compared to the group of women (OR (95 % CI): 4.17 (1.070–16.82), χ2 = 4.17, P = 0.04). Comparison of the odds of observing the genotype G/G, G/A, AA in the group of men with degeneration of the intervertebral disc L5-S1 showed a statistically significant 4.06 times predominance of the genotype G/A (OR (95 % CI): 4.06 (1.23–13.38), χ2 = 4.17, P = 0.04). The most probable model of heredity for COL11A1rs1676486 is dominant OR (95 % CI): 2.08 (1.03–4.21), χ2 = 4.26, P = 0.04. Associations of COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 structure-forming collagens of the gelatinous nucleus with degeneration of L5-L4 intervertebral discs were not detected.\u0000Conclusions. The COL2A1rs2276454 may be protective for the development of L5-S1 intervertebral disc degeneration in men (OR (95 % CI): 0.27 (0.10–0.80), χ2 = 6.02, Р = 0.015). COL2A1rs1793953 is not associated with degeneration of intervertebral discs L4-L5, L5-S1. С/T COL9","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"25 3 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79740471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19)","authors":"CD O. V V. V. Cherkaskyi B, Riabokon, Y. Riabokon","doi":"10.14739/2310-1237.2022.3.266544","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.266544","url":null,"abstract":"Aim. The aim of our work is to establish the prognostic significance of demographic indicators and the Charlson comorbidity index (CCI) in oxygen-dependent patients with coronavirus disease (COVID-19).\u0000Material and methods. The research included 211 oxygen-dependent patients with COVID-19: I group – 94 patients who recovered; II group – 117 patients, the disease ended fatally. We used the WHO age classification when analyzing the age structure of patients. The Charlson comorbidity index was calculated for each patient. The patients were divided into groups Statistical data processing was carried out in the program Statistica for Windows 13 (StatSoft Inc., No. JPZ804I382130ARCN10-J).\u0000Results. It was established that the median age of the ІІ group patients was higher (P < 0.001) than patients the I in group. Elderly patients were more often registered in the ІІ group than among patients in group I (25.6 % vs. 8.5 %, P = 0.001). Middle-aged patients were more often registered in the І group than among patients in the II group (34.0 % vs. 19.4 %, P = 0.02). According to the result of the ROC analysis, the prognostic value of the age of the patients was established, namely, under conditions of age >66 years (AUC = 0.636, Р = 0.002), the probability of a fatal outcome of COVID-19 was significant.\u0000Analysis of the influence of comorbid conditions on the risk of COVID-19 fatal outcome in oxygen-dependent patients according to the CCI showed that the absence of comorbid pathology was more common among patients of group I than among patients of group II (12.8 % vs. 2.6 %, P = 0.004). The level of CCI in patients of the II group significantly exceeded the corresponding indicator of the patients of the I group (P < 0.01), who recovered. According to the obtained result of the ROC analysis, the prognostic value of this indicator was established, namely under the conditions of the CCI index >5 in oxygen-dependent patients with COVID-19 (AUC = 0.652, P < 0.001) the probability of fatal outcome of the disease was significant.\u0000Conclusions. In oxygen-dependent patients with COVID-19, patient age and comorbidity are associated with disease outcome. Under conditions of age >66 years (AUC = 0.636, P = 0.002) and the Charlson comorbidity index >5, the probability of a fatal outcome of the disease is significant (AUC = 0.652, P < 0.001).","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"26 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87558057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Senile asthenia as a predictor of the severity of the perioperative period in elderly and senile patients","authors":"M. Danyliuk, S. M. Zavhorodnii, A. Rylov, M. Kubrak, I. Pertsov","doi":"10.14739/2310-1237.2022.3.260273","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.260273","url":null,"abstract":"The aim. To evaluate the effectiveness of the diagnosis of senile asthenia using the Edmonton Frail scale in emergency abdominal surgery and to determine its impact on the severity of the perioperative period.\u0000Materials and methods. The study included 81 patients with acute cholecystitis on the background of gallstone disease, who were assessed for senile asthenia using the Edmonton Frail scale. For the reliability of the obtained results, only patients who were urgently hospitalized to the surgical department with gynecology beds of the emergency hospital with clinical symptoms of acute cholecystitis were included. All patients received treatment in only one department and according to the standards and clinical protocols of this clinic. Based on the Edmonton Frail score, all patients were divided into two groups. The comparison group included 50 (61.7 %) patients who did not have senile asthenia. The main group included 31 (38.3 %) patients diagnosed with senile asthenia.\u0000Results. Surgical treatment in both groups was carried out on an urgent basis using total intravenous anesthesia with artificial lung ventilation. According to the type of surgical intervention in both groups, preference was given to minimally invasive methods. Laparoscopic cholecystectomy in the comparison group was performed in 49 (98.0 %) patients, and only one patient (2.0 %) was converted and operation continued from the mini-access. In the main group, all surgical interventions were performed by the laparoscopic method, U = 759.50, P = 0.8841. Analyzing the results of the duration parameters and the need for prolonged mechanical ventilation, it can be seen that it progressively increases in patients with asthenia: in the comparison group 61.50 (48.00; 75.00) minutes, and in the main 93.84 (60.00; 80.00), U = 513.50, P = 0.0112. Also, we noted that in patients with senile asthenia, the number of postoperative complications increases: in the comparison group, there were only 2 (4.0 %) postoperative complications, while in the main group – 7 (22.6 %), U = 556.00, Р = 0.0337.\u0000Summarizing the results, it can be seen that due to increase of the frequency of postoperative complications and increase of the need for prolonged artificial ventilation of the lungs, the length of hospital stay of patients with senile asthenia increased: in the comparison group it was 7.9 ± 2.2 days, and in the main group 9.7 ± 3.2 days, U = 530.50, P = 0.0177.\u0000Conclusions. In our opinion, the Edmonton Frail scale is effective in diagnosing the severity of senile asthenia in elderly and senile patients in emergency abdominal surgery due to its simplicity and speed of use. The overall severity of the condition, heart failure in patients with senile asthenia lead to increase in the duration of surgery and the total duration of artificial lung ventilation: in the comparison group 39.52 (30.00; 45.00) minutes, while in the main group 49.19 (35.00; 50.00) minutes, U = 482.50, P = 0.0046. The duration of me","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"23 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83734305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chronic atrophic gastritis as a precancer: the evolution of ideas from the Sydney consensus to Maastricht VI","authors":"Y. Stepanov, Y. Haidar, O. A. Maltseva","doi":"10.14739/2310-1237.2022.3.269011","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.269011","url":null,"abstract":"Aim. The purpose of the work is the evolution of systems and classifications of gastritis: Sydney Consensus (1990), Houston Modification (1994), OLGA/OLGIM (2008), Kyoto (2014), MAPS II (2019), Maastricht IV (2022).\u0000Materials and methods. During the work, 25 sources of information were used.\u0000Results. Chronic atrophic gastritis (ChAG) is a clinical and morphological diagnosis, and the presented clinical forms (types) of gastritis have characteristic morphological criteria. According to the Sydney system, changes in the antrum and body of the stomach are described separately. This has led to a lack of clear risk stratification criteria for CG and also complicates the objective analysis of regression of inflammation and atrophy. OLGA/OLGIM systems were proposed to determine the stage of atrophy and IM. The authors of the Kyoto consensus add and clarify the etiological section of ChAG. In MAPS II, ChAG and IM are considered precancerous conditions, as they increase the risk of developing gastric cancer and are the background for the occurrence of dysplasia and adenocarcinoma. For patients with dysplasia and the absence of visible changes in the mucous membrane, high-resolution endoscopy with staining is recommended. They should be examined after 6 months for a high degree of dysplasia and after 12 months for a low degree of dysplasia. Patients with IM and one localization have a high risk of developing gastric cancer. However, the high risk does not give the right to follow up in the majority of cases when high-quality endoscopy with biopsy does not show severe atrophy. Patients with IM of one location, with a family history of cancer, or with incomplete IM and persistence of H. pylori chromo endoscopy with biopsy must be done once every 3 years. Patients with extended fields of atrophic aggression (pronounced atrophic changes) or IM in the antrum and body, OLGA/OLGIM III/IV should be screened with chromoendoscopy with biopsy every 3 years. Patients with significant atrophy and familial cancer benefit from chromoendoscopy and biopsy every 1–2 years after initial diagnosis. Patients with autoimmune gastritis are recommended to be screened every 3–5 years. According to Maastricht VI, H. pylori is the main etiological factor of gastric adenocarcinoma, including proximal gastric cancer.\u0000Conclusions. After careful study and analysis, we came to the conclusion about the gradual development of the principles of evidence-based medicine in the issue of improving the clinical and morphological diagnosis of chronic atrophic gastritis as a precancerous of the stomach.\u0000 ","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"105 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73376419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of antireflux surgery effectiveness in patients with hiatal hernia","authors":"A. Klymenko, B. Kravchenko, V. Klymenko, L. Serhieieva, S. Kravchenko, V. Tkachov","doi":"10.14739/2310-1237.2022.3.253116","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.253116","url":null,"abstract":"The generally accepted gold standard in the surgical treatment of hiatal hernias is laparoscopic fundoplication with cruroplasty. At the same time, the problem of choosing the best method of fundoplication to improve the results of surgical intervention remains disputable.\u0000Aim. Determination of the effectiveness of antireflux interventions and the frequency of postoperative dysphagia in patients with esophageal hernia.\u0000Materials and methods. The results of 38 patients in the early and late postoperative period, operated with the use of Nissen and Toupet fundoplication, with an integrated exhaustive examination of the manifestations of dysphagia syndrome were analyzed. 17 (44.7 %) patients (first group) underwent laparoscopic posterior crurorraphy with Nissen fundoplication in the Short-Floppy-Nissen modification, and 21 (55.3 %) patients (second group) underwent posterior crurorraphy with Toupet fundoplication.\u0000Results. In the postoperative period, the intensity of pain on the rating scale was minimal in 70.6 % and 71.4 %; moderate in 23.5 % and 14.3 %; strong in 5.9 % and 14.3 % of the patients in the first and second groups, respectively. The first degree of dysphagia (the ability to ingest liquid food and fluids) was observed in 5 of 17 (29.4%) patients of the first group, with subsequent regression in 4 of 5 patients within 5 days; in the second group there was no dysphagia. When comparing the results of all scales of integrated analysis of the quality of life of the patients of both groups, no significant difference was found between them.\u0000Conclusions. The obtained data demonstrate the compatibility of both methods, in the absence of differences in quality of life and patient’s satisfaction in the late postoperative period. Differences in the frequency of dysphagia syndrome after surgery indicate the need for a more differentiated approach to the choice of fundoplication technique.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"16 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86664454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative characteristics of the regeneration of the femur bone of rats at intramedullary osteosynthesis using medical steel and carbon-carbon composite material","authors":"V. Chornyi, P. Bohdanov","doi":"10.14739/2310-1237.2022.3.265186","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.265186","url":null,"abstract":"The aim of this study was to compare the morphological features of rat femoral bone regeneration during intramedullary osteosynthesis using medical steel and carbon-carbon composite material.\u0000Materials and methods. All animals were divided into two groups. A fracture of the thighbone was simulated by surgical intervention. In the first group, medical steel was used for intramedullary fixation of fragments; in the second group, fragments were fixed using a carbon-carbon composite material. The morphological, morphometric, histological, histochemical, immunohistochemical and X-ray methods was used, the bone regenerate was studied on the 30th day, 6 and 12 months after the surgical intervention. There were established expression of immunohistochemical markers CD-34 and Ki-67 using the ImageJ program. The statistical analysis of the obtained results was performed by the methods of variational statistics using the program Statistica 13.0.\u0000Results. In the group of animals where composite material was used, on the 30th day after surgery, a statistically significant increase in the expression of the relative area occupied by CD-34+ structures compared to the second group of animals was established (4.80 ± 0.40 in the group in which the composite material was used and 2.80 ± 0.30 in group in which the medical steel was used). Also a statistically significant increase in the expression of the Ki-67+ marker was established (5.20 ± 0.36 in the group in which the composite material was used and 2.48 ± 0.32 in group in which the medical steel was used). With inspection microscopy, faster rates of osseointegration and regeneration of the fracture site were observed in the group of animals in which the composite material had been used compared to the other group of animals due to the stimulation of vascular endothelium growth. The data of the histological examination coincide with the data of the X-ray examination at all the periods of observation.\u0000Conclusions. The use of carbon-carbon composite material during intramedullary osteosynthesis accelerates bone regeneration pace due to the angiogenic effect, which is confirmed by increase in the expression of markers of proliferative activity Ki-67+ and the marker of vascular endothelium CD-34+ in the group of experimental animals in 30 days.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"27 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75563854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction depending on left ventricle ejection fraction","authors":"V. Tashchuk, R. A. Bota, M. A. Al Salama","doi":"10.14739/2310-1237.2022.3.267268","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.267268","url":null,"abstract":"Aim: to evaluate the dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) depending on ejection fraction of left ventricular (LV).\u0000Material and methods. The study group consisted of 23 consecutive patients with STEMI admitted to the Regional Clinical Cardiology Center in Chernivtsi, who underwent successful reperfusion treatment by PCI. To evaluate inflammatory markers, a complete blood count (CBC) was assessed at admission, and on day 10 of hospital stay on the background of optimal drug therapy.\u0000Results. It was found that patients with STEMI and reduced left ventricular ejection fraction (LVEF) (group 2) at admission had a significantly higher leukocyte count (P < 0.05) and an increase in the absolute neutrophils (P < 0.01) with significantly higher inflammatory markers: neutrophil-to-lymphocyte ratio (NLR) (P < 0.01), monocyte-to-lymphocyte ratio (MLR), systemic immune inflammation index (SII) (P < 0.01), systemic inflammation response index (SIRI) (P < 0.01), aggregate index of systemic inflammation (AISI) (P < 0.05), and integrated index of inflammation (III) (P < 0.05). On day 10 of treatment, the analysis of inflammatory markers showed that in patients of group 2, NLR (P < 0.01) and SII (P < 0.05) remained significantly higher than in STEMI patients with preserved LVEF (group 1). At the study of the changes in leukocyte-based inflammatory markers in STEMI patients under the influence of optimal drug therapy after PCI, a decrease (P < 0.05) in NLR, MLR, SII, SIRI, IIII, and an increase in (P < 0.05) LMR were observed.\u0000Conclusions. CBC of inflammatory markers at admission identifies the risk of adverse cardiovascular events and determines measures to regulate the activity of the inflammatory process in STEMI.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"366 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80352163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity","authors":"T. Ashcheulova, K. Kompaniiets, N. Herasymchuk, I. Sytina","doi":"10.14739/2310-1237.2022.3.266425","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.3.266425","url":null,"abstract":"Among the comorbid conditions that significantly worsen quality of life and life expectancy are the chronic obstructive pulmonary disease and heart failure. Difficulties of drug therapy are the mutually exclusive approaches in the treatment of chronic obstructive pulmonary disease and concomitant cardiovascular pathology.\u0000Aim of this study was to provide scientific evidence of the possible use of the combined drug LCZ696 (angiotensin receptor neprilysin inhibitor, ARNI), which contains neprilysin inhibitor sacubitril (AHU377) and angiotensin II blocker valsartan, in patients with congestive heart failure.\u0000The article presents a review of the literature. It was demonstrated that the cause of mortality in patients with chronic obstructive pulmonary disease could be both changes in the respiratory system and complications in the cardiovascular system. It has been shown that progressive chronic obstructive pulmonary disease leads to the formation of pulmonary hypertension, right ventricular hypertrophy, decrease in its systolic function, subsequent dilatation of the right ventricle, and development of right ventricular heart failure, which is one of the most serious and difficult tests in the treatment process. The further development of such a combined pathology is left ventricular heart failure.\u0000The role of the system of natriuretic peptides, namely brain natriuretic peptide, brain natriuretic propeptide, C-type natriuretic peptide, and N-terminal precursor of C-type natriuretic peptide, as markers of chronic obstructive pulmonary disease and heart failure has been discussed. Natriuretic peptide is currently a recognized marker of heart failure, the high value of which is achieved for determining the prognosis and stratification of the risk of heart failure. Natriuretic peptide acts as a vasodilator, provides antiproliferative activity through the G-dependent protein kinase pathway and promotes bronchodilation, causing the release of acetylcholine from bronchial epithelial cells.\u0000Conclusions. All these properties suggest that natriuretic peptides may be a potential treatment in patients with cardiac complications and chronic obstructive pulmonary disease. The best way to prolong life of natriuretic peptide is to inhibit degradation of the natriuretic peptide with the neprilysin inhibitor sacubitril.\u0000 ","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"28 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82251113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Matrix metallopeptidase 9 and outcome prediction in patients with acute coronary syndrome","authors":"A. Bilchenko, I. Vyshnevska, Y. Hilova, EF GI M. P. Kopytsia A, “L. T. Malaya Therapy, А. О. Більченко, І. Р. Вишневська, Я. В. Гільова, Микола Павлович Копиця","doi":"10.14739/2310-1237.2022.2.251670","DOIUrl":"https://doi.org/10.14739/2310-1237.2022.2.251670","url":null,"abstract":"The aim of this review was to analyse the scientific literature data on matrix metallopeptidase 9 and to analyse the available information on its prognostic value as a marker of negative outcome in the short- and long-term prognosis in patients with acute coronary syndrome.\u0000Materials and methods. In our study was used a recursive literature search strategy at PubMed. The following criteria for inclusion in the analysis were defined – a prospective study in patients with acute coronary syndrome that had data on the effect of MMP-9 levels on short-term and/or long-term outcomes, including mortality and major adverse сardiovascular events. Review articles, clinical cases, animal studies, and studies with insignificant statistical data were not included in the analysis. The depth of the initial search was set at 15 years with a search for similar articles in citations. We selected 5 studies for meta-analysis. Meta-Essentials 1.5 was used for the analysis. Odds ratio and 95 % confidence interval were calculated using the Haenszel method. The association between MMP-9 levels and short-term and long-term outcomes (mortality and major adverse CV events) was determined. The statistically significant level was defined as P < 0.05.\u0000Results. The analysis showed no significant association between the level of MMP-9 and the outcome (OR = 1.39; 95 % CI = 0.25–7.79; P = 0.595; I2 = 78 %).\u0000Conclusions. Matrix metallopeptidase 9 is a promising marker for further investigation of its predictive strength of outcome. Despite the opposite results of single studies and no significant association of MMP-9 with outcome further research on this issue is a promising direction.","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"84 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83070310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}